{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:59:42Z","timestamp":1790809182275,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":457,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Idiopathic portal hypertension (IPH) is a rare cause of intrahepatic portal hypertension. Data on natural history and prognosis of IPH are limited. We sought to describe the complications and long-tem outcome of IPH by retrospectively studying 69 biopsy-proven cases of IPH. Mean duration of follow-up was 6.7 \u00b1 4.6 years. All patients had evidence of portal hypertension (PH) at diagnosis, and 42% were symptomatic. Variceal bleeding (VB) was the most common manifestation. In those without bleeding at diagnosis, 74% had varices at first endoscopy. In those with large varices, the 1-year probability of first bleeding despite primary prophylaxis was 9%. The 1-year probability of rebleeding was 22%. Ascites and hepatic encephalopathy was documented in 26% and 7% of patients, respectively, at least once during the clinical course. The 1-year probability of developing portal vein thrombosis (PVT) was 9%, and 53% of patients receiving anticoagulation achieved recanalization. Human immunodeficiency virus (HIV) infection and VB at diagnosis were the independent predictors of PVT. Seven patients died (6 as a result of an IPH-related cause) and 2 were transplanted. Probability of liver transplantation\u2013free survival was 82% at 10 years. Presence of a severe associated disorder and ascites as a presenting symptom were associated with poor survival. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: Variceal bleeding is a major complication of IPH. Using, in IPH patients, the same management approach for PH as in cirrhosis is safe and maintains a low incidence of first bleeding and rebleeding in IPH patients. PVT is a frequent complication, particularly in those with HIV infection. Despite several complications, overall survival of patients with IPH is considerably good. (Hepatology 2014;59:2276\u20132285)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26904","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T23:45:02Z","timestamp":1382571902000},"page":"2276-2285","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":190,"title":["Idiopathic portal hypertension: Natural history and long-term outcome"],"prefix":"10.1097","volume":"59","author":[{"given":"Sith","family":"Siramolpiwat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Seijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Berzigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles","family":"Garcia-Criado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Darnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Turon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Hernandez-Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Garcia-Pag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20251014","first-page":"526534","article-title":"Noncirrhotic portal fibrosis: current concepts and management.","volume":"17","author":"Sarin","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R2-28-20251014","doi-asserted-by":"crossref","first-page":"275280","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic noncirrhotic intrahepatic portal hypertension in the West: a reevaluation in 28 patients.","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"key":"R3-28-20251014","doi-asserted-by":"crossref","first-page":"17071714","DOI":"10.1038\/ajg.2009.165","article-title":"Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.","volume":"104","author":"Chang","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R4-28-20251014","doi-asserted-by":"crossref","first-page":"10711081","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension.","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatology"},{"key":"R5-28-20251014","doi-asserted-by":"crossref","first-page":"875885","DOI":"10.1111\/apt.12049","article-title":"Risk factors and outcome of HIVassociated idiopathic noncirrhotic portal hypertension.","volume":"36","author":"Schouten","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-28-20251014","doi-asserted-by":"crossref","first-page":"762768","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.","volume":"53","author":"de Franchis","year":"2010","journal-title":"J Hepatol"},{"key":"R7-28-20251014","doi-asserted-by":"crossref","first-page":"398413","DOI":"10.1007\/s12072-007-9010-9","article-title":"Noncirrhotic portal fibrosisidiopathic portal hypertension: APASL recommendations for diagnosis and treatment.","volume":"1","author":"Sarin","year":"2007","journal-title":"Hepatol Int"},{"key":"R8-28-20251014","first-page":"455461","article-title":"Obliterative portal venopathy: portal hypertension is not always present at diagnosis.","volume":"54","author":"CazalsHatem","year":"2011","journal-title":"J Hepatol"},{"key":"R9-28-20251014","doi-asserted-by":"crossref","first-page":"227235","DOI":"10.1007\/s10620-010-1278-2","article-title":"Noncirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors.","volume":"56","author":"Eapen","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R10-28-20251014","doi-asserted-by":"crossref","first-page":"978983","DOI":"10.1111\/j.1478-3231.2005.01151.x","article-title":"Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan.","volume":"25","author":"Matsutani","year":"2005","journal-title":"Liver Int"},{"key":"R12-28-20251014","doi-asserted-by":"crossref","first-page":"280282","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right.","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"key":"R13-28-20251014","doi-asserted-by":"crossref","first-page":"270281","DOI":"10.1055\/s-0028-1085095","article-title":"Intrahepatic portal venopathy and related disorders of the liver.","volume":"28","author":"Chawla","year":"2008","journal-title":"Semin Liver Dis"},{"key":"R14-28-20251014","doi-asserted-by":"crossref","first-page":"627634","DOI":"10.1002\/lt.20431","article-title":"Liver transplantation for severe intrahepatic noncirrhotic portal hypertension.","volume":"11","author":"Krasinskas","year":"2005","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"R15-28-20251014","first-page":"S68S92","article-title":"The management of portal hypertension: rational basis, available treatments and future options.","volume":"48","author":"Bosch","year":"2008","journal-title":"J Hepatol"},{"key":"R16-28-20251014","first-page":"922938","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.","volume":"46","author":"GarciaTsao","year":"2007","journal-title":"Hepatology"},{"key":"R17-28-20251014","doi-asserted-by":"crossref","first-page":"13631365","DOI":"10.1136\/bmj.298.6684.1363","article-title":"Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with noncirrhotic portal fibrosis.","volume":"298","author":"Kiire","year":"1989","journal-title":"BMJ"},{"key":"R18-28-20251014","doi-asserted-by":"crossref","first-page":"12381245","DOI":"10.1053\/j.gastro.2010.06.017","article-title":"Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension.","volume":"139","author":"Sarin","year":"2010","journal-title":"Gastroenterology"},{"key":"R19-28-20251014","doi-asserted-by":"crossref","first-page":"441444","DOI":"10.2169\/internalmedicine.32.441","article-title":"The prognosis of idiopathic portal hypertension in Japan.","volume":"32","author":"Ichimura","year":"1993","journal-title":"Intern Med"},{"key":"R20-28-20251014","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1440-1746.2002.02596.x","article-title":"Noncirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature.","volume":"17","author":"Dhiman","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R21-28-20251014","doi-asserted-by":"crossref","first-page":"272277","DOI":"10.1097\/COH.0b013e3283473405","article-title":"Influence of antiretroviral therapy on liver disease.","volume":"6","author":"Kovari","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"R22-28-20251014","doi-asserted-by":"crossref","first-page":"691697","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"key":"R23-28-20251014","doi-asserted-by":"crossref","first-page":"776783","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"R24-28-20251014","first-page":"903A","article-title":"Algorithm for the management of portal vein thrombosis (PVT) in patients with cirrhosis: a prospective casecontrol study.","volume":"52","author":"Senzolo","year":"2010","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26904","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201406000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:54:20Z","timestamp":1760457260000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201406000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26904","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}